1154741-20-4

Basic information

• Product Name: 8-Bromo-5-chloroquinoline
• Synonyms: 8-Bromo-5-chloroquinoline;5-chloro-8-broMoquinoline;8-Bromo-5-chloro-1-azanaphthalene
• CAS NO: 1154741-20-4
• Molecular Formula: C₉H₅BrClN
• Molecular Weight: 242.4997
• EINECS: -0
• Mol File: 1154741-20-4.mol

Chemical Properties

• Boiling Point: 325.7±22.0 °C(Predicted)
• Appearance: /
• Density: 1.673
• Storage Temp.: 2-8°C
• PKA: 1.24±0.29(Predicted)
• CAS DataBase Reference: 8-Bromo-5-chloroquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Bromo-5-chloroquinoline(1154741-20-4)
• EPA Substance Registry System: 8-Bromo-5-chloroquinoline(1154741-20-4)

Safety Data

• Hazardous Substances Data: 1154741-20-4(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
8-Bromo-5-chloroquinoline is used as a key intermediate in the synthesis of various organic compounds, particularly in the pharmaceutical and agrochemical industries. Its unique structural features, including the bromine and chlorine atoms, facilitate targeted chemical reactions, enabling the creation of a wide range of derivative compounds with specific therapeutic or functional properties.
Used in Laboratory Research:
As a fundamental reagent, 8-Bromo-5-chloroquinoline is employed in laboratory research to explore its chemical properties, reactivity, and potential applications. Researchers utilize this compound to study reaction mechanisms, investigate its interactions with other molecules, and develop new synthetic methodologies.
Used in Medicinal Chemistry:
8-Bromo-5-chloroquinoline is used as a building block in the design and development of novel pharmaceutical agents. Its quinoline core is a common structural motif in many bioactive compounds, making it a valuable component in the creation of new drugs with potential therapeutic benefits.
Used in Agrochemical Development:
In the agrochemical industry, 8-Bromo-5-chloroquinoline serves as a precursor for the synthesis of various pesticides and insecticides. Its unique chemical properties allow for the development of effective crop protection agents that can target specific pests while minimizing environmental impact.
Used in Material Science:
8-Bromo-5-chloroquinoline's structural characteristics make it a candidate for the development of new materials with specific properties, such as electronic, optical, or catalytic functions. Its potential applications in material science include the creation of organic semiconductors, sensors, or catalysts for various industrial processes.
Used in Environmental Analysis:
Due to its reactivity and unique chemical properties, 8-Bromo-5-chloroquinoline can be employed in environmental analysis for the detection and monitoring of pollutants or contaminants. Its use in analytical chemistry may involve the development of new methods for the identification and quantification of hazardous substances in various environmental matrices.
Used in Educational Purposes:
8-Bromo-5-chloroquinoline is utilized in educational settings to teach students about the properties and reactions of heterocyclic compounds. It serves as a practical example of a quinoline derivative, helping students understand the principles of organic chemistry and the importance of structural composition in determining a compound's properties and reactivity.

Upstream product

• 823-57-4 2-bromo-5-chloroaniline 
• 107-02-8 acrolein 

Relevant articles and documents

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein c, X, Y, R2, R4 and R5 are defined herein, are useful as inhibitors of HIV replication.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The present invention relates to compounds of formula (I) wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula I : wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.